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ABSTRACT 
 
3D microtissue models, especially cancer microtissue model, are potentially applicable for new drug 
testing because 3D microtissue reveals more realistic drug response, characterizes the disease and 
mimics the tumor in human body. In this paper, we report the integration of oral squamous cell 
carcinoma (OSCC) cell line (ORL-48) into 3D microtissue after two weeks of microencapsulation in 
calcium alginate microbeads that were produced based on the flicking technique. The microtissues 
contained highly proliferative cells as indicated by Alamar blue assay. The viable microtissues 
formed were extracted from the calcium alginate shell by means of alginate lyase. As revealed by 
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field emission scanning electron microscopy (FE-SEM), the extracted 3D microtissues were 
characterized by inhomogeneous microtissue surface but good cell integrity via self-secreted 
extracellular matrix proteins. DAPI staining showed the proliferative behavior of cells in multilayer 
structure. These microtissues were able to spread into 2D monolayer after being transferred to grow 
on petri dishes. The 3D cultured microtissues of ORL-48 could be potentially useful for cancer 
therapeutic drug assessment in-vitro.  
 
 
Keywords: 3D cell culture; calcium alginate; microbeads; microtissue; ORL-48; oral squamous cell 
carcinoma. 
 
1. INTRODUCTION  
 
In routine two-dimensional (2D) animal cell 
culture, cells are tightly spread and coupled to 
the culture flask in monolayer which is contrary to 
cells in vivo [1]. In 2D culture, cell to cell 
interaction is mainly concentrated at the 
boundary of the flattened cells [2] and the spatial 
organization of the cells in 2D is distorted when 
compared with the three-dimensional (3D) tissue 
in vivo [3]. Cells grown in 2D spread involuntarily 
by producing limited amount of extracellular 
matrix proteins due to the contactless spreading 
of cells [4]. Thus, 3D cell culture promotes cells 
growth in all directions with neighboring and 
surrounding cells which is believed to provide a 
better cell model for cancer research because 3D 
culture restores specific morphological, multi-
stratified structure and biochemical features 
similar to the corresponding tissue in vivo [5]. 
Hence, modeling the intricacy of cancer using 2D 
culture on plastic ware is far from representing 
the tumor within the patient [6]. 3D microtissues 
reveal a more realistic drug response, 
predictively characterizes the disease and 
mimics the tumor in human body [7]. Previous 
report demonstrated that, culturing cancer cells 
in 2D monolayer conditions do not respond well 
to the cancer therapeutics due to dissimilar 
manner of the cancer cells in 3D models [6]. 
Thus, 3D cell culture systems are useful in drug 
discovery because their advantages in revealing 
more physiologically information and more 
predictive data for in vivo tests [8]. It is now 
widely accepted that the tumor spheroids, a 
three-dimensional model more closely resembles 
the initial avascular stages of small solid tumors 
in vivo [9,10]. 
 
Head and neck cancers are the sixth most 
common malignant tumors worldwide, with more 
than 650,000 new cases and 350,000 deaths 
each year [11]. Oral squamous cell carcinoma 
(OSCC) is common among the most devastating 
head and neck cancer subtypes especially in 
South-East and South-Central Asia. In countries 
such as Bangladesh, Pakistan, Sri Lanka and 
India, OSCC is the most common cancer among 
men with a five year survival rate of 50–60% [12]. 
Consequently, the establishment of 3D 
microtissue in vitro models to study tumors will 
help in the understanding of molecular events 
related with the development of these cancers 
[13]. 
 
Microbeads or microcapsules have wide 
applications in biomedical engineering field that 
include drug delivery, encapsulation of 
biomolecules, tissue padding and tissue 
regeneration [14-18]. Different strategies have 
been applied to produce 3D microtissues [19]. 
The cells are usually encapsulated in calcium 
alginate microbeads that can be easily removed 
once the microtissues are formed. Calcium 
alginate is a white milky colored, gelatinous and 
water insoluble substance that can be created 
through the addition of aqueous sodium alginate 
to aqueous calcium chloride [18]. The porosity of 
calcium alginate provides exchange of gases, 
nutrients and catabolites for the encapsulated 
cells which support the growth of microtissues in 
encapsulation [20]. Alginate is currently 
recognized as a ready for clinical application 
material by the US Food and Drug Administration 
(FDA) [20,21]. 
 
Microencapsulation based on flicking technique 
is a promising technique developed by our group 
in producing high volume of microtissues of 
keratinocytes within a narrow distribution of size 
(230–280 µm) [22]. This method for generation of 
microbeads of cells is highly reproducible. In this 
work, flicking technique will be applied to 
encapsulate oral squamous cell carcinoma 
(ORL-48) cells [13,23] in calcium alginate 
microbeads leading to the microtissue formation. 
The biochemical, proliferation and biophysical 
structures of the microtissues will be investigated 
using phase contrast microscopy, DAPI staining, 
live and dead cells staining, Alamar blue assay, 
Field Emission Scanning Electron Microscopy 
(FE-SEM) and 3D microtissue replating. The 
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contribution of this research that has not been 
reported elsewhere is expected to be useful for 
generating 3D cancer microtissues for 
therapeutic drug assessment. 
 
2. MATERIALS AND METHODS 
 
2.1 ORL-48 Cell Culture 
 
Oral squamous cell carcinoma (ORL-48) cell 
lines were provided by Cancer Research 
Malaysia (CRM). The cells were cultured in a 75 
cm2 tissue-treated culture flask containing DMEM 
(Dulbecco's Modified Eagle’s Medium, Gibco®) 
supplemented with penicillin (100 units/ml, Sigma 
Aldrich, UK), fungizone (2.5 mg/l, Invitrogen, 
USA), streptomycin (100 mg/ml, Invitrogen, USA) 
and 10% fetal bovine serum (Invitrogen, USA). 
Upon reaching confluency, the media was 
removed from the cell culture flask and the flask 
was washed three times with Hank’s Balanced 
Salt Solution (HBSS, Life Technologies, USA). 
After removing the HBSS solution, 3 ml of trypsin 
(0.5 mg/ml, Invitrogen, USA) was deposited into 
the flask and the flask was incubated in a 
humidified 5% CO2 for about 5 mins. 
Subsequently, the flask was examined under a 
phase contrast microscope (Eclipse TS100, 
Nikon, Tokyo, Japan) to ensure that all the cells 
were detached from the surface of the culture 
flask. 6 ml of DMEM (containing 10% fetal bovine 
serum) was then deposited to halt the 
trypsinization process. Subsequently, the cell 
suspensions were transferred to a 15 ml 
polypropylene tube and centrifuged for 5 min at 
269 ×g. The supernatant were discarded and the 
cells were re-suspended in 100 µl of 2 w/v% 
concentration sodium alginate solution. Then, the 
cell-sodium alginate solution with an approximate 
cell density of 9.42 × 107 cells/ml was ready for 
the microencapsulation experiments. 
  
2.2 Preparation of Solutions and 
Microencapsulation Setup in Sterile 
Conditions  
 
Sodium alginate powder (W201502-1KG, Sigma 
Aldrich, St. Louis, MO, USA) and calcium 
chloride anhydrous, granular (C1016-500G, 
Sigma Aldrich, St. Louis, MO, USA) are the 
materials used to prepare the biopolymer. 2 
w/v% concentration of sodium alginate solution 
and 1 w/v% concentration of calcium chloride 
solution were used for gelation of calcium 
alginate (Ca-Alg) microbeads. The calcium 
chloride solution was filtered using a 0.2 µm 
PTFE membrane Acrodisc® syringe filter (Pall® 
Life Sciences, Port Washington, NY) before 
used. A flicking device was coupled to a syringe 
pump (NE-4002X, New Era, Farmingdale, NY, 
USA) to microencapsulate cells in Ca-Alg 
microbeads based on the flicking technique as 
described previously [22]. An ethylene 
tetrafluoroethylene (ETFE) cable tie with a length 
of 2.5 cm was tied to the shaft of a direct current 
geared motor to be constructed into a flicking 
device or flicker. The flicker produces rebounding 
force on the syringe needle to force the ejected 
droplets of cell suspension sodium alginate from 
the syringe needle to disperse and drop into a 
petri dish (60 × 15 mm) containing 4 ml of 1 
w/v% calcium chloride solution. The distance 
between the needle tip and surface of calcium 
chloride solution was fixed at 5 cm. Tiny droplets 
of cell-suspension sodium alginate solution were 
submerged to calcium chloride solution to form 
cell encapsulated calcium alginate microbeads in 
the petri dish. 
 
2.3 Microencapsulation of ORL-48 Cells 
 
In the microencapsulation experiment, the cell-
alginate solution was filled in a 0.5 ml BD 
(Becton, Dickinson and Company, United States) 
insulin syringe (29 Gauge) and the syringe was 
inserted to the syringe pump holder.  The orifice 
of the tapped needle tip was faced downward to 
the calcium chloride solution containing in the 
petri dish. The flicking speed of the flicker and 
flow rate of the syringe pump were set at 80 rpm 
and 4 µl/min, respectively to produce microbeads 
with a size ranging from 230-280 µm that are 
suitable to encapsulate cells [22]. After 5 mins of 
flicking, the cell-alginate microbeads were left to 
be further polymerized in the calcium chloride 
bath for another 5 mins. When the microbeads of 
calcium alginates were formed, the calcium 
chloride solution was removed and then the 
microbeads were submerged into 1.5 ml of 
DMEM. The cell encapsulated microbeads were 
incubated at 37°C in a 5% CO2 humidified 
incubator. The culture media (DMEM) was 
refreshed every two days. The growth of cells in 
the microbeads was monitored every 24 hours in 
an inverted phase contrast microscope (TS100, 
Nikon, Tokyo, Japan) linked to a digital Go-5 
CCD camera (QImaging, Surrey, Canada). 
 
2.4 DAPI Staining  
 
DAPI (4', 6-diamidino-2-phenylindole) is a 
fluorescent stain that binds strongly to 
the deoxyribonucleic acid (DNA), and was used 
to determine the distribution of cells in the 
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calcium alginate microbeads. It is able to stain 
both live and fixed cells [24]. 0.5 µg/ml of DAPI 
(Sigma Aldrich, St. Louis, MO, USA) stain was 
prepared in HBSS solution. The cells 
encapsulated in the calcium alginate microbeads 
(3, 9 and 15 days of culture) were washed with 
HBSS before they were stained with DAPI 
solution for 20 mins. After 20 mins of staining, 
the DAPI solution was removed and the cells 
encapsulated microbeads were washed with 
HBSS solution. The stained cells in calcium 
alginate microbeads were observed in a BX53 
Olympus fluorescence microscope mounted with 
a DP72 CCD camera (Olympus, Tokyo, Japan). 
 
2.5 Live and Dead Cells Staining 
 
LIVE/DEAD® Kits for mammalian cells (Molecular 
Probes
®
 Product Brands) purchased from Life 
Technologies were used to stain the viable and 
dead cells of microtissue (after 15 days of 
culture) encapsulated in calcium alginate 
microbeads. 5 µl of calcein-AM and 20 µl of 
ethidium homodimer-1 (EthD-1) were mixed with 
10 ml of HBSS solution to form 2 µM of calcein-
AM and 4 µM of EthD-1 mixed solution. The 
container of the mixed solution was wrapped with 
aluminum foil and sonicated for 10 mins in an 
ultrasonic bath sonicator. The mixed solution was 
used to stain the cells of microtissue 
encapsulated in calcium alginate microbeads. 
The microtissue containing in the microbeads 
were washed with HBSS solution before staining. 
The calcium alginate microbeads were stained 
with the diluted calcein-AM and EthD-1 solution 
for 20 mins in dark. After 20 mins of staining, the 
staining solution was removed and the cells 
encapsulated microbeads were washed with 
HBSS solution again. Then, the stained 
microtissue in alginate microbeads were 
observed in a BX53 fluorescence microscope 
(Olympus, Tokyo, Japan) immediately. The 
purpose of carrying out live and dead cells 
stainings were to determine whether the 
aggregated cells (microtissue) in the calcium 
alginate microbeads were viable.  
 
2.6 Alamar® Blue Assay 
 
Negative control, control and samples of 
microencapsulated cells were treated with 
Alamar blue assay to investigate the proliferation 
of ORL-48 cells in microencapsulation after 15 
days of culture. Before the experiment, the 
microencapsulated cells were washed three 
times in HBSS. After washing, three pieces of 
microcapsules containing cells were added to 
each of the eight wells in a single column of a 96 
well plate. For the control, three pieces of 
alginate microcapsules without cells were also 
added to each of the eight wells in another 
column. The third column of the 96 well plate 
was set as the negative control. Then, the 
negative control, control and samples were 
added with 90 µl of DMEM media and 10 µl of 
Alamar blue (Invitrogen, Carlsbad, California, 
USA). The 96 well plate was incubated in a CO2 
perfused incubator at 37°C for 24 hours. After 
incubation, the absorbance of the Alamar blue 
assay in the 96 well plate at 570 nm was 
scanned using a Multiskan
TM
 GO microplate 
spectrophotometer (Thermo Fisher scientific, 
Waltham, Massachusetts, USA). The 
absorbance data was acquired using SkanIt™ 
Software and exported in Microsoft Excel format. 
The absorbance was computed and expressed in 
mean ± standard deviation (SD). Similar 
experiments were repeated three times. 
Statistical significant differences between control, 
negative control and sample were determined 
using student’s t-test in Microsoft Excel for 
p<0.05.  
 
2.7 Extraction of 3D Microtissues with 
Alginate Lyase  
 
Calcium alginate microbeads containing 3D 
microtissues of ORL-48 after 15 days of culture 
were soaked in a DMEM medium containing 0.2 
mg/ml of alginate lyase (A1603, Sigma Aldrich, 
St. Louis, MO, USA) for degradation of alginate 
capsules [25]. Within 2 mins of soaking, the 
degradation of the calcium alginate was 
observed and recorded in a phase contrast 
microscope. 
 
2.8 FE-SEM Scanning of the Extracted 3D 
Microtissues 
 
Field emission scanning electron microscopy 
(FE-SEM, JSM-7600F, JOEL, Tokyo, Japan) was 
used to observe the morphology of the 3D 
microtissues. The extracted 3D microtissues by 
alginate lyase were washed three times with 
HBSS followed by 4% of formaldehyde (F8775, 
Sigma Aldrich, St. Louis, MO, USA) fixation for 
24 hours at 4°C. After fixation, the 3D 
microtissues were air dried and sputter coated 
with gold nanoparticles before FE-SEM 
scanning. An auto fine coater (JFC–1600, JOEL, 
Tokyo, Japan) was used to coat the specimens 
with a gold layer at a thickness of 8 nm for 30 
seconds in automatic mode. The parameter 
settings of the FE-SEM during imaging were 2 kV 
of acceleration voltage with a secondary electron 
image (SEI) detector that provides 150×, 300× 
and 1500 × of magnifications. 
 
2.9 3D Microtissues Replating 
 
3D microtissues replating is a simple and easy 
method to investigate viability of the extracted 3D 
microtissues after alginate lyase. The extracted 
3D microtissues were washed three times with 
HBSS and transferred to a tissue
polystyrene petri dish (35 × 10 mm) fo
2 ml of fresh DMEM was added into the culture 
petri dish and the behavior of the 3D 
microtissues in the culture dish was monitored.
 
3. RESULTS AND DISCUSSION
 
The size of microbeads produced by the flicking 
technique was small enough to serve as a 
condition required for microencapsulation of cells 
with a flicking speed of 80 rpm and flow rate of 4 
µl/min to produce microbeads size in the range 
of 230-280 µm (Fig. 1). The microencapsu
cells were able to grow due to the suitable size of 
small-diameter (less than 300 µm) microbeads. 
This size range of microbeads could decrease 
mass transfer resistance caused by the 
encapsulation material in which allowing greater 
oxygen and nutrient availability for cells dwelling 
inside the microbeads [26,27]. Nonetheless, 
higher cell growth rate is an advantage of small 
microbeads over the larger microbeads for cells 
encapsulation because larger microbeads have 
more empty space at the same cell concentration 
[27]. In addition, smaller microbeads size might 
minimize or overcome the formation of a necrotic 
region at the center of cells resulting from 
insufficient nutrition and oxygenation 
 
Fig. 2 shows the results of ORL-48 cells grown in 
the calcium alginate microbeads with a cell 
density of 9.42 × 107 cells/ml. On the first day of 
microencapsulation, individual ORL
closely packed at high density in the calcium 
alginate microbeads (Fig. 2(a)). Every cell is 
adhered to the adjacent or neighboring cells. 
2(b) shows the ORL-48 cells grown in the 
calcium alginate bead and turned into 
aggregation after 3 days of culture. As time 
progressed from 5 to 11 days of culture, more 
aggregation of cells were observed as shown in 
Fig. 2(c-f). The progressive formation of 
microtissues was obvious when individual cells 
can hardly be distinguished on the day 13 and 15 
of culture (Fig. 2(g-h)). On day 15 of culture, thick 
and dark cloudy microtissues could be seen in 
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lated 
[25]. 
-48 cells were 
Fig. 
the phase contrast microscopy indicating the 
maturation of the 3D microtissue formed. The 
use of alginate for cell culture is encouraging 
plausible because it is a biodegradable polymer 
that mimics the extracellular matrix and supports 
both cell functions and metabolism 
However, cells produced catabolites and waste 
into culture media over prolong culture period. 
This caused the media to turn acidic and thus, 
increased the biodegradability for some of the 
alginate microbeads over time. As a result, this 
led to the rupture of alginate membrane and 
leaking of cells from the microcapsule. This 
problem can be greatly reduced by replenishing 
the media every two days to reduce the acidity of 
the media caused by the metabolism of th
A few hundreds of microtissues with good cell 
integrity were able to be harvested after the issue 
was addressed. 
 
 
 
Fig. 1. The calcium alginate microbeads size 
used for cells encapsulation, (a) optical 
photomicrograph of microbeads and (b) si
distribution graph of microbeads. 
(Scale bar: 100 µm)
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and 
[18,28]. 
e cells. 
 
 
ze 
          
 
Fig. 2. The encapsulated ORL-48 cells in microbeads of calcium alginate at Day (a) 1, (b) 3, 
(c) 5, (d) 7, (e) 9, (f) 11, (g) 13 and (h) 15 of 
Fig. 3 (a-c) shows the results of DAPI staining on 
ORL-48 cells in a calcium alginate microbead
grown after 3, 9 and 15 days, respectively. The 
blue dots in the DAPI staining represent the 
nucleus of the ORL-48 cells. On day 3 of culture 
(Fig. 3(a)), individual punctuated dots of nucleus 
in loose spaces can be clearly identified. On day 
9 of culture, the number of the blue dots or nuclei 
seemed to increase and filled up the empty 
spaces of microbeads that were observed on day 
Wong et al.; ARRB, 13(4): 1-12, 2017; Article no.
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culture. (Scale bar: 100 µm)
 
 
3 of culture (Fig. 3(b)). On day 15 of culture
(Fig. 3(c)), these dots were indistinguishable due 
to the formation of highly and closely packed
cell aggregations with very limited spaces in the 
microtissue. The DAPI staining results 
were useful to indicate the proliferative behavior 
of cells in the microencapsulation that were in 
good agreement with the densely packed 
microtissues observed in the phase contrast 
microscopy. 
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Fig. 3. DAPI stainings of ORL-48 cells encapsulated in the microbeads
Day (a) 3, (b) 9 and (c) 15 of culture. (Scale bar: 100 µm)
 
Fig. 4 shows the result of live and dead cell 
stainings of the 3D microtissue of ORL
encapsulated in a calcium alginate microbead 
after 15 days of culture. Green staining indicates 
live cells and red staining indicates death cells. 
As shown in Fig. 4, majority of the cells in the 
microtissues cultured in the calcium alginate 
microbeads were stained in green which 
indicated the cells were alive. The viabi
of microtissue suggested that the cells received 
enough nutrients and gases allowing them to be 
alive in the encapsulation after prolong period of 
culture and a constant change of media.  
Nonetheless, the high viability of cells 
determined could be attributed to the gentle 
flicking mechanism and polymerization process. 
These processes had presented safe 
encapsulation of the cells. In our experiment, the 
flicking technique has successfully produced high 
throughput and viable 3D microtissues of or
squamous cell carcinoma cells (N = 80 per min 
of flicking). This is a positive achievement in 
comparison to the micro-nozzle array 
method which yielded a lower viability (
of cells [17] that could be due to the post 
cleaning treatment with lipase and high 
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-48 
lity result 
al 
                    
~70 %)  
productivity of microbeads generated that was 
inversely proportional to the number of cells 
encapsulated. 
 
 
Fig. 4. Live and dead cell stainings of ORL
cells encapsulated in calcium alginate 
microbeads after 15 days of culture. Green 
stain of calcein-Am characterizes the live 
cells as indicated by an arrow 
(Scale bar: 100 µm)
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The absorbance of the Alamar blue for the 
negative control (media) and control (alginate 
microcapsules) at 0.5367 ± 0.0765 and 0.5059 ± 
0.0668 show no statistically differences (
0.4056), respectively. In comparison with the 
negative controls and controls, the results of 
Alamar blue assay in Fig. 5(a) indicated that the 
ORL-48 cells in the microtissue sample were 
highly proliferative at an absorbance of 0.7539 ± 
0.0853. The absorbance of the sample is 
statistical significant different from the control (
= 0, p <0.05) and negative control (
0.05). This result is supported by a prev
[12] which revealed that ORL-48 derived from 
stage IV tumors exhibited with high growth rate 
and has a short doubling time of 15 hours. The 
absorbance can be visually observed in the 96 
well plate as shown in Fig. 5(b). The highly 
metabolic cells converted non-
resazurin in media into pink resorufin via the 
reduction reactions. The amount of colorimetric 
indicator produced is proportional to the quantity 
of live cells. 
 
The calcium alginate microbead membrane was 
completely dissolved within 1 min of immersion in 
alginate lyase. Before alginate lyase, the 3D 
microtissue was encapsulated spherically in 
the calcium alginate microbead as shown in 
 
Fig. 5. (a) Absorbance graph for negative control, control and sample of microencapsulated 
cells after 24 hours culture in Alamar blue. The absorbance is expressed in mean ± SD. (b) The 
Alamar blue assay for the control, negative control and sample in a 96 well p
colorimetric indicator after conversion of Alamar blue by cells. Purple characterizes the 
original absorbance of Al
 *indicates significance of
(a) 
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toxic purple 
    
   
Fig. 6(a). However, the released 3D microtissue 
from the alginate capsule was slightly e
into irregular shape without confinement of the 
spherical alginate capsule as shown in 
Clearly, the microtissues encapsulated in the 
microbeads may not be spherical in shape but 
their appearances seen were defined by the 
shape of the alginate microbeads. The extracted 
microtissues were characterized by good 
integrity of cells with no fragment of loose tissue 
[25]. The microtissues remained intact even after 
gentle mechanical disturbance or handling which 
indicated strong cell-cell adhesion in the 
microtissues. The extracellular matrix proteins 
were strongly developed and established 
amongst the cells during formation of the 
microtissues. Enzymatic dissociation of cells 
using EDTA-trypsin could be a means to prove 
that the cells were bound by the ECM proteins 
[29]. 
 
In order to further analyze the surface 
morphology of 3D ORL-48 microtissues and to 
understand the cell adhesion to the matrix, FE
SEM was used to investigate the shape and 
surface morphology of the microtissues released 
from the alginate capsules. Fig. 
7(b) show the FE-SEM image of 3D ORL
microtissue at ×150 and ×300 magnifications, 
       
 
late. Pink is the 
amar blue mixed with DMEM media 
 p < 0.05 (p= 0) as assessed by Student's t-test 
 
(b) 
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Fig. 6(b). 
-
7(a) and Fig. 
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Fig. 6. The phase contrast images of microtissues of ORL-48: (a) before and (b) after 
application of alginate lyase. (Scale bar: 100 µm) 
 
 
 
Fig. 7. FE-SEM images of 3D ORL-48 microtissue with different magnifications: (a) ×150 (Scale 
bar: 100 µm), (b) ×300 (Scale bar: 10 µm) and (c) ×1500 (Scale bar: 10 µm) 
 
respectively. Similar to previous research [30,31], 
the FE-SEM results showed that the microtissues 
harvested from the calcium alginate microbeads 
were in the form of spheroids. In the FE-SEM 
image, the surface of the 3D spheroids of ORL-
48 was not characterized by individualized cells 
protruding. The cells were well fused in the 
extracellular matrix that was indicated by the 
heterogeneous surface of microtissue (Fig. 7(c)). 
As reported in [32], solid tumors (in vivo) are 
organ-like structures that are heterogeneous and 
structurally complex. Solid tumors are 
characterized by malignant cells, ECM and 
several types of normal cells [33]. The multi 
structural tissues organization and denser cell 
density in tumors was suggested to be a cause 
of drug resistance [32,33]. Thus, a 3D in vitro 
microtissue model might reveal a more realistic 
drug response and mimics the tumor in vivo. 
 
3D microtissue of ORL-48 cells replating was 
performed to rapidly investigate the viability and 
migration functionality of the cells of microtissue 
after alginate lyase. On the first day of replating, 
the microtissue (Fig. 8(a)) was suspended in the 
culture medium. After 24 hours of replating, the
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Fig. 8. The phase contrast photograph of replating extracted 3D ORL-48 microtissue at: (a) Day 
1, (b) Day 2, (c) Day 3 and (d) Day 4. (Scale bar: 100 µm) 
 
microtissue attached to the surface of the culture 
dish and cells started to migrate out of the 
microtissue as shown in Fig. 8(b). The 
attachment of microtissue on culture dish was 
confirmed by gently shaking the culture dish and 
the microtissue did not detach or float in the 
culture medium. Fig. 8(c) shows that more 2D 
monolayer of cells were formed and spread out 
from the 3D microtissue on Day 3. The 3D 
microtissue was completely disintegrated and 
grew into 2D monolayer of cells on Day 4 as 
shown in Fig. 8(d). This experiment showed that 
the cells after experiencing the alginate lyase 
process were viable and retained their basic 
ability to migrate and proliferate. The cells of 3D 
microtissue preferably attached to a tissue-
culture treated dish. This could be due to the 
stiffness and the strong negatively charged 
surface of the tissue-culture treated dish that was 
able to attract the deposition of positively 
charged amino acids to support cells adhesion 
[34]. If the OSSC spheroid model is to be applied 
and treated with an inhibitor to the actin filament 
polymerization such as cytochalasin-B, this 
replating method can be applied in future work to 
provide information on the effects of the inhibitor 
to the migratory ability of the cancer cells out of 
the microtissues. Hence, the overall cancer 
microtissues model will be useful for screening 
cancer therapeutic agent. 
 
4. CONCLUSION 
 
A 3D cell model of oral squamous cell carcinoma 
cell line was successfully produced based on the 
microencapsulation technique of flicking. This 
model is potentially useful for regenerative 
medicine and cancer therapeutic drug research. 
With the microencapsulation of flicking 
technique, ORL-48 cells encapsulated in calcium 
alginate microbeads were able to grow into 
microtissues after being cultured for 
approximately two weeks. The live and dead cell 
stainings indicated that the cells in the 
microtissues were highly viable after the alginate 
lyase process and the cells were reported to be 
functional via the replating experiment. The ORL-
48 cells grown in the microtissues were highly 
proliferative as indicated by the Alamar blue 
assay. The DAPI staining indicated the 
proliferative behavior of the cells in multi-layer 
structure during the microtissues formation. The 
DAPI result also showed that the cells were 
densely packed and highly integrated in the 
microtissues. The microtissues were not ideally 
spherical as what was observed in the 
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entrapment of microbeads. FE-SEM microscopy 
confirmed the organization of cells into 3D 
spheroids of cells surrounded by extracellular 
matrix. We believe that the viable cancer 
microtissues are suitable to be applied for 
studying novel cancer therapeutics and 
investigating oral squamous cell carcinoma 
pathogenesis.  
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